Contraindications for Magnesium Sulfate Injection
Magnesium sulfate has very few absolute contraindications, but should not be used in patients with myasthenia gravis, heart block, or severe renal failure without dose adjustment and close monitoring.
Absolute Contraindications
Based on FDA labeling and clinical guidelines, the following represent true contraindications:
Myasthenia Gravis
- Magnesium sulfate can precipitate or worsen myasthenic crisis by interfering with neuromuscular transmission 1
- This includes other neuromuscular disorders, particularly mitochondrial myopathies where case reports document severe muscle damage even at therapeutic doses 2
Heart Block
- Complete heart block or significant AV nodal conduction abnormalities are contraindications
- At toxic levels (6-10 mmol/L), magnesium causes AV nodal conduction block, bradycardia, and cardiac arrest 3
Relative Contraindications Requiring Extreme Caution
Renal Insufficiency
- This is the most clinically important relative contraindication 1
- Magnesium is renally excreted; impaired kidney function leads to accumulation and toxicity
- Maximum dose in severe renal insufficiency: 20 grams per 48 hours (versus 30-40 grams per 24 hours normally) 1
- Requires frequent serum magnesium level monitoring
- Patients with renal failure can develop toxicity at much lower doses 3
Concurrent Calcium Channel Blocker Use
- Myocardial depression may occur when magnesium is combined with calcium channel blockers (particularly IV formulations) 4
- This combination can cause precipitous blood pressure drops
- Use with extreme caution and close hemodynamic monitoring
Important Clinical Caveats
Duration of Use in Pregnancy
- Continuous administration beyond 5-7 days in pregnancy causes fetal harm 1, 5, 6
- Leads to fetal hypocalcemia, skeletal demineralization, osteopenia, and neonatal fractures
- FDA changed classification from Category A to Category D specifically for prolonged use
- Short-term use (<48 hours) for eclampsia prophylaxis or fetal neuroprotection remains appropriate 5, 6
Monitoring Requirements During Administration
The following must be present before each dose:
- Patellar reflexes intact (loss indicates impending toxicity)
- Respiratory rate ≥12 breaths/minute (respiratory depression occurs at 4-5 mmol/L) 3
- Urine output ≥25-30 mL/hour (oliguria increases toxicity risk) 3
Antidote Availability
- Calcium gluconate must be immediately available as the antidote for magnesium toxicity 3
- Empirical calcium administration is lifesaving in overdose situations
Not Contraindications
Despite common misconceptions:
- Pregnancy itself is NOT a contraindication - magnesium sulfate is indicated for eclampsia prevention and treatment 7, 1
- Hypotension alone is not a contraindication, though it requires careful BP monitoring
- Concurrent use with other antihypertensives is acceptable with appropriate monitoring 7
Clinical Bottom Line
The evidence shows magnesium sulfate is remarkably safe when used appropriately with proper monitoring. The key is recognizing patients with impaired renal function (who require dose reduction and frequent level checks), those with neuromuscular disorders (absolute contraindication), and ensuring treatment duration in pregnancy does not exceed 5-7 days to avoid fetal skeletal toxicity.